Literature DB >> 17032053

Jug r 4, a legumin group food allergen from walnut (Juglans regia Cv. Chandler).

Mikhael Wallowitz1, W Rich Peterson, Sandie Uratsu, Sarah S Comstock, Abhaya M Dandekar, Suzanne S Teuber.   

Abstract

Allergy to walnut is the most frequently reported tree nut allergy in the United States. Walnut 2S albumin, a vicilin-like protein, and a lipid transfer protein allergen have previously been described. Our objective was to clone and express a cDNA encoding a legumin group protein, assess IgE-binding with sera from walnut allergic patients, and investigate cross-reactivity with selected nuts. Primers were used to obtain the cDNA by 5' and 3' rapid amplification of cDNA ends from walnut mRNA. The cDNA was subcloned into the pMAL-c2X vector and the recombinant fusion protein, named rJug r 4, was expressed in Escherichia coli. The obtained cDNA encoded a precursor protein with a predicted molecular weight of 58.1 kD, which showed significant sequence homology to hazelnut and cashew legumin allergens. Serum IgE from 21 of 37 (57%) patients bound the rJug r 4 fusion protein. In vitro cross-reactivity was demonstrated with hazelnut, cashew, and peanut protein extracts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032053     DOI: 10.1021/jf061329s

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  12 in total

1.  In vivo and T cell cross-reactivity between walnut, cashew and peanut.

Authors:  Michael Kulis; Laurent Pons; A Wesley Burks
Journal:  Int Arch Allergy Immunol       Date:  2008-09-19       Impact factor: 2.749

2.  Walnut allergy in peanut-allergic patients: significance of sequential epitopes of walnut homologous to linear epitopes of Ara h 1, 2 and 3 in relation to clinical reactivity.

Authors:  Leonard Rosenfeld; Wayne Shreffler; Ludmilla Bardina; Bodo Niggemann; Ulrich Wahn; Hugh A Sampson; Kirsten Beyer
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

Review 3.  From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack.

Authors:  Verena Fuhrmann; Huey-Jy Huang; Aysegul Akarsu; Igor Shilovskiy; Olga Elisyutina; Musa Khaitov; Marianne van Hage; Birgit Linhart; Margarete Focke-Tejkl; Rudolf Valenta; Bulent Enis Sekerel
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

4.  Purification, crystallization and initial crystallographic characterization of brazil-nut allergen Ber e 2.

Authors:  Feng Guo; Tengchuan Jin; Andrew Howard; Yu Zhu Zhang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-10-26

5.  The 11S globulin Sin a 2 from yellow mustard seeds shows IgE cross-reactivity with homologous counterparts from tree nuts and peanut.

Authors:  Sofía Sirvent; Martial Akotenou; Javier Cuesta-Herranz; Andrea Vereda; Rosalía Rodríguez; Mayte Villalba; Oscar Palomares
Journal:  Clin Transl Allergy       Date:  2012-12-11       Impact factor: 5.871

6.  Food production and processing considerations of allergenic food ingredients: a review.

Authors:  Pedro A Alvarez; Joyce I Boye
Journal:  J Allergy (Cairo)       Date:  2011-12-01

7.  Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy.

Authors:  Luis Diego Archila; David Jeong; Mariona Pascal; Joan Bartra; Manel Juan; David Robinson; Mary L Farrington; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2015-03-13       Impact factor: 10.793

8.  Is There Any Necessity to Prescribe Consumption of Walnuts Cooked by Different Processing Techniques to Patients With Walnut Allergy?

Authors:  Jae Won Oh
Journal:  Allergy Asthma Immunol Res       Date:  2018-07       Impact factor: 5.764

Review 9.  Cross-reactivity of peanut allergens.

Authors:  Merima Bublin; Heimo Breiteneder
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

Review 10.  Current perspectives on tree nut allergy: a review.

Authors:  Tamar Weinberger; Scott Sicherer
Journal:  J Asthma Allergy       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.